Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic Heart Failure.

Winkel1, Costanzo

  • 1Heart Failure and Cardiac Transplant Program, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Suite 439, Chicago, IL 60612, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplant Coronary Vasculopathy.

Current treatment options in cardiovascular medicine·2001
Same author

Myocarditis.

Current treatment options in cardiovascular medicine·2000
Same author

Characteristics of nest soil, but not geographic origin, influence cold hardiness of hatchling painted turtles.

Journal of thermal biology·2000
Same author

Search for fractionally charged nuclear fragments in relativistic heavy ion collisions.

Physical review. C, Nuclear physics·1996
Same author

Experimental observation of the lowest 1 Sigma u+ valence state of O2.

Physical review. A, Atomic, molecular, and optical physics·1995
Same author

Charge-changing interactions of 197Au at 10 GeV/nucleon in collisions with targets from H to Pb.

Physical review. C, Nuclear physics·1995
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Aggressively treat early heart failure with medications like ACE inhibitors and beta-blockers to improve survival. Early diagnosis of left ventricular dysfunction is key for effective heart failure management.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Early diagnosis and treatment of left ventricular (LV) dysfunction are crucial for preventing heart failure progression and improving patient survival.
  • Patients with risk factors such as coronary disease or hypertension require echocardiography to assess LV function.

Purpose of the Study:

  • To outline an aggressive early treatment strategy for heart failure.
  • To guide physicians on the appropriate use of various pharmacologic agents and diagnostic tools for managing LV dysfunction.

Main Methods:

  • Review of current treatment guidelines for heart failure.
  • Emphasis on early diagnosis through echocardiography for at-risk patients.
  • Stepwise pharmacologic management including ACE inhibitors, beta-blockers, diuretics, and other agents based on disease severity and patient tolerance.

Related Experiment Videos

Main Results:

  • Angiotensin-converting enzyme (ACE) inhibitors are recommended as initial therapy for LV systolic dysfunction unless contraindicated.
  • Beta-adrenergic blocking drugs should be added to therapy for stable patients with mild to moderate heart failure.
  • Specific recommendations for diuretics, digoxin, spironolactone, warfarin, and angiotensin receptor blockers (ARBs) based on clinical status.

Conclusions:

  • Aggressive early treatment of heart failure, particularly left ventricular dysfunction, significantly improves survival.
  • A tailored, stepwise approach to pharmacotherapy, guided by patient symptoms and ejection fraction, is essential.
  • Referral to specialized heart failure centers is recommended for patients with severe or refractory symptoms.